ELAN Elanco Animal Health Incorporated

ELAN Elanco Animal Health Incorporated

Healthcare · Drug Manufacturers - Specialty & Generic

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

POC $22.44 · VWAP $23.42 · +0.6% vs 12m avg buyer

pullback vol: compressedgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CFO, Director + 3 others bought $1.5M, Aug 10–21

Coverage

1 related campaign

Watchlists @livestock-disease

ELAN Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ELAN belongs to, members best 30-day change first — ELAN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings ELAN reports in 20 days Nov 6

Last report Aug 5

Reported the quarter ending 2026-06-30: revenue $1.37B, diluted EPS $0.11, net income $54M (SEC filing). Across the print the stock moved -5.5% (close before → first close after).

full note →

Against street estimates

How ELAN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 0.270.34 GAAP ≠ +26.5%Beat
May 6 0.340.40 GAAP ≠ +16.6%Beat
Feb 24 0.120.13+11.2%Beat
Nov 5 '25 0.130.19 GAAP ≠ +43.9%Beat
Aug 7 '25 0.200.26 GAAP ≠ +29.5%Beat
May 7 '25 0.300.37 GAAP ≠ +21.5%Beat
Feb 25 '25 0.150.14-5.8%Miss
Nov 7 '24 0.120.13 GAAP ≠ +11.0%Beat
Types
Aug 5 Catalyst ELAN earnings